by Richard Daverman, PhD
October 1, 2013 -- Sanofi is taking the “big picture” approach to emerging markets, according to its CEO, refusing to stop investing in developing countries because of pricing pressure and government crackdowns. In fact, Sanofi will continue to seek acquisitions in emerging markets, said Chris Viehbacher, Sanofi’s CEO, and it will presumably also forge partnerships, as it has done in China. There will be occasional setbacks, he continued, but the markets are too important to ignore. More details....
Stock Symbol: (NYSE: SNY)
Help employers find you! Check out all the jobs and post your resume.
